{Reference Type}: Journal Article
{Title}: Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate.
{Author}: Byrd AL;Qu X;Lukyanchuk A;Liu J;Chen F;Naughton KJ;DuCote TJ;Song X;Bowman HC;Zhao Y;Edgin AR;Wang C;Liu J;Brainson CF;
{Journal}: Stem Cell Reports
{Volume}: 18
{Issue}: 1
{Year}: 01 2023 10
{Factor}: 7.294
{DOI}: 10.1016/j.stemcr.2022.11.009
{Abstract}: Aberrant lung cell differentiation is a hallmark of many lung diseases including chronic obstructive pulmonary disease (COPD). The EZH2-containing Polycomb Repressive Complex 2 (PRC2) regulates embryonic lung stem cell fate, but its role in adult lung is obscure. Histological analysis of patient tissues revealed that loss of PRC2 activity was correlated with aberrant bronchiolar cell differentiation in COPD lung. Histological and single-cell RNA-sequencing analyses showed that loss of EZH2 in mouse lung organoids led to lowered self-renewal capability, increased squamous morphological development, and marked shifts in progenitor cell populations. Evaluation of in vivo models revealed that heterozygosity of Ezh2 in mice with ovalbumin-induced lung inflammation led to epithelial cell differentiation patterns similar to those in COPD lung. We also identified cystathionine-β-synthase as a possible upstream factor for PRC2 destabilization. Our findings suggest that PRC2 is integral to facilitating proper lung stem cell differentiation in humans and mice.